{"id":458713,"date":"2021-03-16T09:03:24","date_gmt":"2021-03-16T13:03:24","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=458713"},"modified":"2021-03-16T09:03:24","modified_gmt":"2021-03-16T13:03:24","slug":"cannalogue-now-accepting-requests-for-clinical-trials-and-research-with-medical-cbd","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/cannalogue-now-accepting-requests-for-clinical-trials-and-research-with-medical-cbd\/","title":{"rendered":"Cannalogue Now Accepting Requests for Clinical Trials and Research with Medical CBD"},"content":{"rendered":"

\nMedical cannabis provider aims to accelerate research efforts throughout North America
\n<\/h2>\n
\n

TORONTO, March 16, 2021 (GLOBE NEWSWIRE) — Canada\u2019s leading provider of medical CBD (cannabidiol) and other cannabinoids, Toronto-based Cannalogue has announced it is now accepting requests for clinical trials and research with medical CBD. Cannalogue is authorized to facilitate the study of medical products in a real-world clinical research environment and is welcoming expressions of interest from companies with approved medical CBD products.<\/p>\n

In an effort to accelerate medical CBD research efforts, and to simultaneously provide high-quality data to regulatory bodies such as Health Canada and the U.S. Food and Drug Administration (FDA), Cannalogue will offer recruitment and evaluation for a wide range of conditions including chronic pain, anxiety, sleep issues, and skin disorders. Additional conditions for study will also be evaluated upon request.<\/p>\n

\u201cGiven the complexity of the clinical trials and research process, Cannalogue\u2019s specialized knowledge allows us to perform a range of tasks on behalf of licensed producers and processors,\u201d says Dr. Mohan Cooray, President and CEO of Cannalogue. \u201cOur hope is to help millions of patients across the world with our findings and to address gaps in traditional medicine with these new plant-derived medicines,\u201d he says.<\/p>\n

Researchers and scientists, academic institutions, doctors and clinics, medical associations, athletic associations, hospitals, pharmaceutical manufacturers, insurance providers, health agencies, FDAs, governments, and other international bodies looking to participate in research are advised to contact Cannalogue.<\/p>\n

For more detailed information including eligibility criteria, please visit www.cannalogue.ca\/research<\/a><\/p>\n


\n
\n \n <\/div>\n

\n
Media Contact:\r\n\r\nMelanie Greco\r\n647-456-2653\r\nmelanie.greco@cannalogue.ca<\/pre>\n<\/p><\/div>\n","protected":false},"excerpt":{"rendered":"
Medical cannabis provider aims to accelerate research efforts throughout North America TORONTO, March 16, 2021 (GLOBE NEWSWIRE) — Canada\u2019s leading provider of medical CBD (cannabidiol) and other cannabinoids, Toronto-based Cannalogue has announced it is now accepting requests for clinical trials and research with medical CBD. Cannalogue is authorized to facilitate the study of medical products in a real-world clinical research environment and is welcoming expressions of interest from companies with approved medical CBD products. In an effort to accelerate medical CBD research efforts, and to simultaneously provide high-quality data to regulatory bodies such as Health Canada and the U.S. Food and Drug Administration (FDA), Cannalogue will offer recruitment and evaluation for a wide range of conditions including chronic pain, anxiety, … <\/p>\n
Continue reading “Cannalogue Now Accepting Requests for Clinical Trials and Research with Medical CBD”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-458713","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nCannalogue Now Accepting Requests for Clinical Trials and Research with Medical CBD - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/cannalogue-now-accepting-requests-for-clinical-trials-and-research-with-medical-cbd\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Cannalogue Now Accepting Requests for Clinical Trials and Research with Medical CBD - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Medical cannabis provider aims to accelerate research efforts throughout North America TORONTO, March 16, 2021 (GLOBE NEWSWIRE) — Canada\u2019s leading provider of medical CBD (cannabidiol) and other cannabinoids, Toronto-based Cannalogue has announced it is now accepting requests for clinical trials and research with medical CBD. Cannalogue is authorized to facilitate the study of medical products in a real-world clinical research environment and is welcoming expressions of interest from companies with approved medical CBD products. In an effort to accelerate medical CBD research efforts, and to simultaneously provide high-quality data to regulatory bodies such as Health Canada and the U.S. Food and Drug Administration (FDA), Cannalogue will offer recruitment and evaluation for a wide range of conditions including chronic pain, anxiety, … Continue reading "Cannalogue Now Accepting Requests for Clinical Trials and Research with Medical CBD"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/cannalogue-now-accepting-requests-for-clinical-trials-and-research-with-medical-cbd\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-03-16T13:03:24+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE5MDkzOSM0MDY2NTc3IzIxOTU2OTk=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cannalogue-now-accepting-requests-for-clinical-trials-and-research-with-medical-cbd\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cannalogue-now-accepting-requests-for-clinical-trials-and-research-with-medical-cbd\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Cannalogue Now Accepting Requests for Clinical Trials and Research with Medical CBD\",\"datePublished\":\"2021-03-16T13:03:24+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cannalogue-now-accepting-requests-for-clinical-trials-and-research-with-medical-cbd\\\/\"},\"wordCount\":261,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cannalogue-now-accepting-requests-for-clinical-trials-and-research-with-medical-cbd\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE5MDkzOSM0MDY2NTc3IzIxOTU2OTk=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cannalogue-now-accepting-requests-for-clinical-trials-and-research-with-medical-cbd\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cannalogue-now-accepting-requests-for-clinical-trials-and-research-with-medical-cbd\\\/\",\"name\":\"Cannalogue Now Accepting Requests for Clinical Trials and Research with Medical CBD - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cannalogue-now-accepting-requests-for-clinical-trials-and-research-with-medical-cbd\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cannalogue-now-accepting-requests-for-clinical-trials-and-research-with-medical-cbd\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE5MDkzOSM0MDY2NTc3IzIxOTU2OTk=\",\"datePublished\":\"2021-03-16T13:03:24+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cannalogue-now-accepting-requests-for-clinical-trials-and-research-with-medical-cbd\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cannalogue-now-accepting-requests-for-clinical-trials-and-research-with-medical-cbd\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cannalogue-now-accepting-requests-for-clinical-trials-and-research-with-medical-cbd\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE5MDkzOSM0MDY2NTc3IzIxOTU2OTk=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE5MDkzOSM0MDY2NTc3IzIxOTU2OTk=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cannalogue-now-accepting-requests-for-clinical-trials-and-research-with-medical-cbd\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Cannalogue Now Accepting Requests for Clinical Trials and Research with Medical CBD\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Cannalogue Now Accepting Requests for Clinical Trials and Research with Medical CBD - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/cannalogue-now-accepting-requests-for-clinical-trials-and-research-with-medical-cbd\/","og_locale":"en_US","og_type":"article","og_title":"Cannalogue Now Accepting Requests for Clinical Trials and Research with Medical CBD - Market Newsdesk","og_description":"Medical cannabis provider aims to accelerate research efforts throughout North America TORONTO, March 16, 2021 (GLOBE NEWSWIRE) — Canada\u2019s leading provider of medical CBD (cannabidiol) and other cannabinoids, Toronto-based Cannalogue has announced it is now accepting requests for clinical trials and research with medical CBD. Cannalogue is authorized to facilitate the study of medical products in a real-world clinical research environment and is welcoming expressions of interest from companies with approved medical CBD products. In an effort to accelerate medical CBD research efforts, and to simultaneously provide high-quality data to regulatory bodies such as Health Canada and the U.S. Food and Drug Administration (FDA), Cannalogue will offer recruitment and evaluation for a wide range of conditions including chronic pain, anxiety, … Continue reading \"Cannalogue Now Accepting Requests for Clinical Trials and Research with Medical CBD\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/cannalogue-now-accepting-requests-for-clinical-trials-and-research-with-medical-cbd\/","og_site_name":"Market Newsdesk","article_published_time":"2021-03-16T13:03:24+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE5MDkzOSM0MDY2NTc3IzIxOTU2OTk=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cannalogue-now-accepting-requests-for-clinical-trials-and-research-with-medical-cbd\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cannalogue-now-accepting-requests-for-clinical-trials-and-research-with-medical-cbd\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Cannalogue Now Accepting Requests for Clinical Trials and Research with Medical CBD","datePublished":"2021-03-16T13:03:24+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cannalogue-now-accepting-requests-for-clinical-trials-and-research-with-medical-cbd\/"},"wordCount":261,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cannalogue-now-accepting-requests-for-clinical-trials-and-research-with-medical-cbd\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE5MDkzOSM0MDY2NTc3IzIxOTU2OTk=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cannalogue-now-accepting-requests-for-clinical-trials-and-research-with-medical-cbd\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/cannalogue-now-accepting-requests-for-clinical-trials-and-research-with-medical-cbd\/","name":"Cannalogue Now Accepting Requests for Clinical Trials and Research with Medical CBD - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cannalogue-now-accepting-requests-for-clinical-trials-and-research-with-medical-cbd\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cannalogue-now-accepting-requests-for-clinical-trials-and-research-with-medical-cbd\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE5MDkzOSM0MDY2NTc3IzIxOTU2OTk=","datePublished":"2021-03-16T13:03:24+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cannalogue-now-accepting-requests-for-clinical-trials-and-research-with-medical-cbd\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/cannalogue-now-accepting-requests-for-clinical-trials-and-research-with-medical-cbd\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cannalogue-now-accepting-requests-for-clinical-trials-and-research-with-medical-cbd\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE5MDkzOSM0MDY2NTc3IzIxOTU2OTk=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE5MDkzOSM0MDY2NTc3IzIxOTU2OTk="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cannalogue-now-accepting-requests-for-clinical-trials-and-research-with-medical-cbd\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Cannalogue Now Accepting Requests for Clinical Trials and Research with Medical CBD"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/458713","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=458713"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/458713\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=458713"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=458713"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=458713"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}